Study title: Comparison of a vector-generated ECG and the standard leads during a bicycle ergometer examination in patients with suspected stenosing CAD.
Lead investigator: Professor Dr. Nicolaus Reifart
Other examiners: Doctoral candidate Jörg Alexander Langanke and Jörg Reifart
Rhön-Klinikum is one of the largest healthcare providers in Germany, operating hospitals, clinics and group medical practices.
Rhön-Klinikum uses CardioSecur to monitor the success of ablation therapy in patients with arrhythmias.
The Staufenklinikum Schwäbisch Gmünd is a community hospital and has been a part of the Network of Ostalb Clinics since 2017. It is also the academic teaching hospital for the University of Ulm.
The Staufenklinikum is carrying out a comparison study between CardioSecur and the standard 12-lead ECG among neonates, toddlers, children, and teenagers.
Universitätsklinikum Heidelberg is one of the largest and most renowned medical centers within Germany. The medical school of the University of Heidelberg is among the leading European biomedical research institutes. It has existed since 1388, making it the oldest in Germany. The joint goal of the hospital and medical school is the development of innovative diagnostics and therapeutics, including their rapid implementation for patients.
The Uniklinik Heidelberg is using CardioSecur in ambulances and helicopters. This project has the title “4-Point (22-lead) ECG as an Alternative to the Classic 12-lead ECG in Emergency Medicine.”
The Universitätsklinikum Hamburg-Eppendorf (UKE) is one of the most modern hospitals within Europe. Highly specialized experts in numerous specialties work together under the same roof. The latest medical technologies, innovative information technology and care-oriented architecture support physicians, nurses, and therapists to foster close interaction between state of the art medicine, research, and teaching. More than 10,000 individuals are employed here to provide round-the-clock care for their patients.
CardioSecur supports the Hamburg City Health Study (HCHS). The HCHS is the largest location-based long-term study in the world. In the next few years, 45,000 Hamburg residents between 45 and 74 years of age will participate. The goal is to better understand the major widespread diseases heart attack, atrial fibrillation, stroke, and dementia, thereby making the city healthier.